BioGaia AB Statistics

Total Valuation

BioGaia AB has a market cap or net worth of GBP 806.17 million. The enterprise value is 712.76 million.

Market Cap	806.17M
Enterprise Value	712.76M

Important Dates

The next estimated earnings date is Friday, July 18, 2025.

Earnings Date	Jul 18, 2025
Ex-Dividend Date	May 8, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.09%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	77.73M

Valuation Ratios

The trailing PE ratio is 31.79.

PE Ratio	31.79
Forward PE	n/a
PS Ratio	7.85
PB Ratio	6.48
P/TBV Ratio	7.22
P/FCF Ratio	31.07
P/OCF Ratio	29.93
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.75, with an EV/FCF ratio of 27.47.

EV / Earnings	28.10
EV / Sales	6.41
EV / EBITDA	18.75
EV / EBIT	19.79
EV / FCF	27.47

Financial Position

The company has a current ratio of 7.81, with a Debt / Equity ratio of 0.02.

Current Ratio	7.81
Quick Ratio	7.01
Debt / Equity	0.02
Debt / EBITDA	0.06
Debt / FCF	0.08
Interest Coverage	318.91

Financial Efficiency

Return on equity (ROE) is 18.72% and return on invested capital (ROIC) is 15.07%.

Return on Equity (ROE)	18.72%
Return on Assets (ROA)	13.18%
Return on Invested Capital (ROIC)	15.07%
Return on Capital Employed (ROCE)	25.19%
Revenue Per Employee	456,368
Profits Per Employee	112,715
Employee Count	225
Asset Turnover	0.65
Inventory Turnover	2.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.65% in the last 52 weeks. The beta is 0.71, so BioGaia AB's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	-15.65%
50-Day Moving Average	115.58
200-Day Moving Average	114.91
Relative Strength Index (RSI)	37.32
Average Volume (20 Days)	5,128

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioGaia AB had revenue of GBP 102.68 million and earned 25.36 million in profits. Earnings per share was 0.25.

Revenue	102.68M
Gross Profit	74.39M
Operating Income	33.24M
Pretax Income	32.32M
Net Income	25.36M
EBITDA	34.44M
EBIT	33.24M
Earnings Per Share (EPS)	0.25

Full Income Statement

Balance Sheet

The company has 88.34 million in cash and 2.13 million in debt, giving a net cash position of 86.21 million.

Cash & Cash Equivalents	88.34M
Total Debt	2.13M
Net Cash	86.21M
Net Cash Per Share	n/a
Equity (Book Value)	124.42M
Book Value Per Share	1.23
Working Capital	101.33M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 26.94 million and capital expenditures -992,821, giving a free cash flow of 25.94 million.

Operating Cash Flow	26.94M
Capital Expenditures	-992,821
Free Cash Flow	25.94M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 72.45%, with operating and profit margins of 32.37% and 24.70%.

Gross Margin	72.45%
Operating Margin	32.37%
Pretax Margin	31.48%
Profit Margin	24.70%
EBITDA Margin	33.54%
EBIT Margin	32.37%
FCF Margin	25.27%

Dividends & Yields

This stock pays an annual dividend of 0.51, which amounts to a dividend yield of 0.50%.

Dividend Per Share	0.51
Dividend Yield	0.50%
Dividend Growth (YoY)	123.93%
Years of Dividend Growth	1
Payout Ratio	54.60%
Buyback Yield	-0.09%
Shareholder Yield	0.41%
Earnings Yield	3.15%
FCF Yield	3.22%

Dividend Details

Stock Splits

The last stock split was on May 18, 2022. It was a forward split with a ratio of 5.

Last Split Date	May 18, 2022
Split Type	Forward
Split Ratio	5

Scores

BioGaia AB has an Altman Z-Score of 25.58.

Altman Z-Score	25.58
Piotroski F-Score	n/a